Biotechnology IndexA group of NASDAQ-listed companies designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The NASDAQ Biotechnology Index (BI) is calculated under a modified capitalisation-weighted methodology.
The BI currently includes Affymetrix, Amgen, Applera Corp-Celera Genomics Group, Biogen, Cephalon, Chiron, COR Therapeutics, Genzyme Corporation, Genentech Inc, Gilead Sciences, Human Genome Sciences, IIDEC Pharmaceuticals, Immunex Corporation, Medimmune, Millennium Pharmaceuticals, Protein Design Labs and Vertex Pharmaceuticals.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.